{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T14:50:05Z","timestamp":1775487005301,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,12,18]],"date-time":"2017-12-18T00:00:00Z","timestamp":1513555200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Hospital Ju\u00e1rez de M\u00e9xico","award":["HJM2280\/13-A"],"award-info":[{"award-number":["HJM2280\/13-A"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s10067-017-3929-6","type":"journal-article","created":{"date-parts":[[2017,12,18]],"date-time":"2017-12-18T03:51:58Z","timestamp":1513569118000},"page":"901-908","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Serum substance P: an indicator of disease activity and subclinical inflammation in rheumatoid arthritis"],"prefix":"10.1007","volume":"37","author":[{"given":"Rosa Elda","family":"Barbosa-Cobos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo","family":"Lugo-Zamudio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Flores-Estrada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lizbeth Teresa","family":"Becerril-Mendoza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Rodr\u00edguez-Henr\u00edquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rub\u00e9n","family":"Torres-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario Ad\u00e1n","family":"Moreno-Eutimio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian","family":"Ramirez-Bello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,18]]},"reference":[{"issue":"5","key":"3929_CR1","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1002\/acr.21649","volume":"64","author":"J Anderson","year":"2012","unstructured":"Anderson J, Caplan L, Yazdany J, Robbins ML, Neogi T, Michaud K, Saag KG, O'Dell JR, Kazi S (2012) Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice. Arthritis Care Res (Hoboken) 64(5):640\u2013647. \n                    https:\/\/doi.org\/10.1002\/acr.21649","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"9","key":"3929_CR2","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1002\/art.24646","volume":"61","author":"M Backhaus","year":"2009","unstructured":"Backhaus M, Ohrndorf S, Kellner H, Strunk J, Backhaus TM, Hartung W, Sattler H, Albrecht K, Kaufmann J, Becker K, Sorensen H, Meier L, Burmester GR, Schmidt WA (2009) Evaluation of a novel 7-joint ultrasound score in daily rheumatologic practice: a pilot project. Arthritis Rheum 61(9):1194\u20131201. \n                    https:\/\/doi.org\/10.1002\/art.24646","journal-title":"Arthritis Rheum"},{"issue":"10","key":"3929_CR3","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1136\/annrheumdis-2011-200963","volume":"71","author":"MF Bakker","year":"2012","unstructured":"Bakker MF, Cavet G, Jacobs JW, Bijlsma JW, Haney DJ, Shen Y, Hesterberg LK, Smith DR, Centola M, van Roon JA, Lafeber FP, Welsing PM (2012) Performance of a multi-biomarker score measuring rheumatoid arthritis disease activity in the CAMERA tight control study. Ann Rheum Dis 71(10):1692\u20131697. \n                    https:\/\/doi.org\/10.1136\/annrheumdis-2011-200963","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"3929_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060635","volume":"8","author":"M Centola","year":"2013","unstructured":"Centola M, Cavet G, Shen Y, Ramanujan S, Knowlton N, Swan KA, Turner M, Sutton C, Smith DR, Haney DJ, Chernoff D, Hesterberg LK, Carulli JP, Taylor PC, Shadick NA, Weinblatt ME, Curtis JR (2013) Development of a multi-biomarker disease activity test for rheumatoid arthritis. PLoS One 8(4):e60635. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0060635","journal-title":"PLoS One"},{"issue":"6","key":"3929_CR5","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1136\/annrheumdis-2012-203158","volume":"72","author":"AN Colebatch","year":"2013","unstructured":"Colebatch AN, Edwards CJ, Ostergaard M, van der Heijde D, Balint PV, D'Agostino MA, Forslind K, Grassi W, Haavardsholm EA, Haugeberg G, Jurik AG, Landewe RB, Naredo E, O'Connor PJ, Ostendorf B, Potocki K, Schmidt WA, Smolen JS, Sokolovic S, Watt I, Conaghan PG (2013) EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis. Ann Rheum Dis 72(6):804\u2013814. \n                    https:\/\/doi.org\/10.1136\/annrheumdis-2012-203158","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"3929_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2015-000237","volume":"2","author":"MA D'Agostino","year":"2016","unstructured":"D'Agostino MA, Boers M, Wakefield RJ, Berner Hammer H, Vittecoq O, Filippou G, Balint P, Moller I, Iagnocco A, Naredo E, Ostergaard M, Gaillez C, Le Bars M (2016) Exploring a new ultrasound score as a clinical predictive tool in patients with rheumatoid arthritis starting abatacept: results from the APPRAISE study. RMD open 2(1):e000237. \n                    https:\/\/doi.org\/10.1136\/rmdopen-2015-000237","journal-title":"RMD open"},{"issue":"1","key":"3929_CR7","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1749-6632.2010.05826.x","volume":"1217","author":"SD Douglas","year":"2011","unstructured":"Douglas SD, Leeman SE (2011) Neurokinin-1 receptor: functional significance in the immune system in reference to selected infections and inflammation. Ann N Y Acad Sci 1217(1):83\u201395. \n                    https:\/\/doi.org\/10.1111\/j.1749-6632.2010.05826.x","journal-title":"Ann N Y Acad Sci"},{"issue":"9 Supp B","key":"3929_CR8","doi-asserted-by":"publisher","first-page":"S09","DOI":"10.18553\/jmcp.2011.17.s9-b.S09","volume":"17","author":"K Farheen","year":"2011","unstructured":"Farheen K, Agarwal SK (2011) Assessment of disease activity and treatment outcomes in rheumatoid arthritis. Journal of managed care pharmacy : JMCP 17(9 Supp B):S09\u2013S13. \n                    https:\/\/doi.org\/10.18553\/jmcp.2011.17.s9-b.S09","journal-title":"Journal of managed care pharmacy : JMCP"},{"issue":"3","key":"3929_CR9","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1002\/art.30129","volume":"63","author":"DT Felson","year":"2011","unstructured":"Felson DT, Smolen JS, Wells G, Zhang B, van Tuyl LH, Funovits J, Aletaha D, Allaart CF, Bathon J, Bombardieri S, Brooks P, Brown A, Matucci-Cerinic M, Choi H, Combe B, de Wit M, Dougados M, Emery P, Furst D, Gomez-Reino J, Hawker G, Keystone E, Khanna D, Kirwan J, Kvien TK, Landewe R, Listing J, Michaud K, Martin-Mola E, Montie P, Pincus T, Richards P, Siegel JN, Simon LS, Sokka T, Strand V, Tugwell P, Tyndall A, van der Heijde D, Verstappen S, White B, Wolfe F, Zink A, Boers M (2011) American College of Rheumatology\/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Arthritis Rheum 63(3):573\u2013586. \n                    https:\/\/doi.org\/10.1002\/art.30129","journal-title":"Arthritis Rheum"},{"issue":"3","key":"3929_CR10","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/sc.2015.206","volume":"54","author":"M Gautam","year":"2016","unstructured":"Gautam M, Prasoon P, Kumar R, Reeta KH, Kaler S, Ray SB (2016) Role of neurokinin type 1 receptor in nociception at the periphery and the spinal level in the rat. Spinal Cord 54(3):172\u2013182. \n                    https:\/\/doi.org\/10.1038\/sc.2015.206","journal-title":"Spinal Cord"},{"issue":"3","key":"3929_CR11","doi-asserted-by":"publisher","first-page":"R416","DOI":"10.1186\/ar1503","volume":"7","author":"O Grimsholm","year":"2005","unstructured":"Grimsholm O, Rantapaa-Dahlqvist S, Forsgren S (2005) Levels of gastrin-releasing peptide and substance P in synovial fluid and serum correlate with levels of cytokines in rheumatoid arthritis. Arthritis research & therapy 7(3):R416\u2013R426. \n                    https:\/\/doi.org\/10.1186\/ar1503","journal-title":"Arthritis research & therapy"},{"issue":"1","key":"3929_CR12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/rheumatology\/32.1.31","volume":"32","author":"A Hernanz","year":"1993","unstructured":"Hernanz A, De Miguel E, Romera N, Perez-Ayala C, Gijon J, Arnalich F (1993) Calcitonin gene-related peptide II, substance P and vasoactive intestinal peptide in plasma and synovial fluid from patients with inflammatory joint disease. Br J Rheumatol 32(1):31\u201335. \n                    https:\/\/doi.org\/10.1093\/rheumatology\/32.1.31","journal-title":"Br J Rheumatol"},{"issue":"1","key":"3929_CR13","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.bbrc.2014.09.090","volume":"453","author":"HS Hong","year":"2014","unstructured":"Hong HS, Son Y (2014) Substance P ameliorates collagen II-induced arthritis in mice via suppression of the inflammatory response. Biochem Biophys Res Commun 453(1):179\u2013184. \n                    https:\/\/doi.org\/10.1016\/j.bbrc.2014.09.090","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"3929_CR14","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1002\/jcp.21317","volume":"215","author":"HJ Im","year":"2008","unstructured":"Im HJ, Li X, Muddasani P, Kim GH, Davis F, Rangan J, Forsyth CB, Ellman M, Thonar EJ (2008) Basic fibroblast growth factor accelerates matrix degradation via a neuro-endocrine pathway in human adult articular chondrocytes. J Cell Physiol 215(2):452\u2013463. \n                    https:\/\/doi.org\/10.1002\/jcp.21317","journal-title":"J Cell Physiol"},{"issue":"3","key":"3929_CR15","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1007\/s10517-015-2951-4","volume":"159","author":"AA Kubanov","year":"2015","unstructured":"Kubanov AA, Katunina OR, Chikin VV (2015) Expression of neuropeptides, neurotrophins, and neurotransmitters in the skin of patients with atopic dermatitis and psoriasis. Bull Exp Biol Med 159(3):318\u2013322. \n                    https:\/\/doi.org\/10.1007\/s10517-015-2951-4","journal-title":"Bull Exp Biol Med"},{"issue":"21","key":"3929_CR16","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1089\/neu.2013.2993","volume":"30","author":"AV Leonard","year":"2013","unstructured":"Leonard AV, Thornton E, Vink R (2013) Substance P as a mediator of neurogenic inflammation after balloon compression induced spinal cord injury. J Neurotrauma 30(21):1812\u20131823. \n                    https:\/\/doi.org\/10.1089\/neu.2013.2993","journal-title":"J Neurotrauma"},{"issue":"10","key":"3929_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0139206","volume":"10","author":"B Lisowska","year":"2015","unstructured":"Lisowska B, Lisowski A, Siewruk K (2015) Substance P and chronic pain in patients with chronic inflammation of connective tissue. PLoS One 10(10):e0139206. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0139206","journal-title":"PLoS One"},{"issue":"4791","key":"3929_CR18","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1126\/science.2433770","volume":"235","author":"M Lotz","year":"1987","unstructured":"Lotz M, Carson DA, Vaughan JH (1987) Substance P activation of rheumatoid synoviocytes: neural pathway in pathogenesis of arthritis. Science (New York, NY) 235(4791):893\u2013895. \n                    https:\/\/doi.org\/10.1126\/science.2433770","journal-title":"Science (New York, NY)"},{"issue":"22","key":"3929_CR19","doi-asserted-by":"publisher","first-page":"4249","DOI":"10.1007\/s00018-016-2293-z","volume":"73","author":"A Mashaghi","year":"2016","unstructured":"Mashaghi A, Marmalidou A, Tehrani M, Grace PM, Pothoulakis C, Dana R (2016) Neuropeptide substance P and the immune response. Cellular and molecular life sciences : CMLS 73(22):4249\u20134264. \n                    https:\/\/doi.org\/10.1007\/s00018-016-2293-z","journal-title":"Cellular and molecular life sciences : CMLS"},{"issue":"7","key":"3929_CR20","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s00726-014-1736-9","volume":"46","author":"M Munoz","year":"2014","unstructured":"Munoz M, Covenas R (2014) Involvement of substance P and the NK-1 receptor in human pathology. Amino Acids 46(7):1727\u20131750. \n                    https:\/\/doi.org\/10.1007\/s00726-014-1736-9","journal-title":"Amino Acids"},{"issue":"9","key":"3929_CR21","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.3899\/jrheum.110425","volume":"38","author":"E Naredo","year":"2011","unstructured":"Naredo E, Wakefield RJ, Iagnocco A, Terslev L, Filippucci E, Gandjbakhch F, Aegerter P, Aydin S, Backhaus M, Balint PV, Bruyn GA, Collado P, Finzel S, Freeston JE, Gutierrez M, Joshua F, Jousse-Joulin S, Kane D, Keen HI, Moller I, Mandl P, Ohrndorf S, Pineda C, Schmidt WA, Szkudlarek M, Conaghan PG, D'Agostino MA (2011) The OMERACT ultrasound task force--status and perspectives. J Rheumatol 38(9):2063\u20132067. \n                    https:\/\/doi.org\/10.3899\/jrheum.110425","journal-title":"J Rheumatol"},{"issue":"2","key":"3929_CR22","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/jcp.20061","volume":"201","author":"TM O'Connor","year":"2004","unstructured":"O'Connor TM, O'Connell J, O'Brien DI, Goode T, Bredin CP, Shanahan F (2004) The role of substance P in inflammatory disease. J Cell Physiol 201(2):167\u2013180. \n                    https:\/\/doi.org\/10.1002\/jcp.20061","journal-title":"J Cell Physiol"},{"key":"3929_CR23","doi-asserted-by":"publisher","unstructured":"Okamura Y, Mishima S, Kashiwakura JI, Sasaki-Sakamoto T, Toyoshima S, Kuroda K, Saito S, Tokuhashi Y, Okayama Y (2017) The dual regulation of substance P-mediated inflammation via human synovial mast cells in rheumatoid arthritis. Allergology international : official journal of the Japanese Society of Allergology. \n                    https:\/\/doi.org\/10.1016\/j.alit.2017.03.002","DOI":"10.1016\/j.alit.2017.03.002"},{"issue":"3","key":"3929_CR24","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3109\/s10165-010-0384-5","volume":"21","author":"T Origuchi","year":"2011","unstructured":"Origuchi T, Iwamoto N, Kawashiri SY, Fujikawa K, Aramaki T, Tamai M, Arima K, Nakamura H, Yamasaki S, Ida H, Kawakami A, Ueki Y, Matsuoka N, Nakashima M, Mizokami A, Kawabe Y, Mine M, Fukuda T, Eguchi K (2011) Reduction in serum levels of substance P in patients with rheumatoid arthritis by etanercept, a tumor necrosis factor inhibitor. Mod Rheumatol 21(3):244\u2013250. \n                    https:\/\/doi.org\/10.1007\/s10165-010-0384-5","journal-title":"Mod Rheumatol"},{"issue":"1","key":"3929_CR25","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1471-2466-11-41","volume":"11","author":"R Ramalho","year":"2011","unstructured":"Ramalho R, Soares R, Couto N, Moreira A (2011) Tachykinin receptors antagonism for asthma: a systematic review. BMC pulmonary medicine 11(1):41. \n                    https:\/\/doi.org\/10.1186\/1471-2466-11-41","journal-title":"BMC pulmonary medicine"},{"issue":"1","key":"3929_CR26","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.berh.2015.04.025","volume":"29","author":"R Ramonda","year":"2015","unstructured":"Ramonda R, Oliviero F, Galozzi P, Frallonardo P, Lorenzin M, Ortolan A, Scanu A, Punzi L (2015) Molecular mechanisms of pain in crystal-induced arthritis. Best Pract Res Clin Rheumatol 29(1):98\u2013110. \n                    https:\/\/doi.org\/10.1016\/j.berh.2015.04.025","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"2","key":"3929_CR27","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1080\/030097498441010","volume":"27","author":"K Sakai","year":"1998","unstructured":"Sakai K, Matsuno H, Tsuji H, Tohyama M (1998) Substance P receptor (NK1) gene expression in synovial tissue in rheumatoid arthritis and osteoarthritis. Scand J Rheumatol 27(2):135\u2013141","journal-title":"Scand J Rheumatol"},{"issue":"2","key":"3929_CR28","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1124\/mol.115.101014","volume":"89","author":"M Sloniecka","year":"2016","unstructured":"Sloniecka M, Le Roux S, Zhou Q, Danielson P (2016) Substance P enhances keratocyte migration and neutrophil recruitment through interleukin-8. Mol Pharmacol 89(2):215\u2013225. \n                    https:\/\/doi.org\/10.1124\/mol.115.101014","journal-title":"Mol Pharmacol"},{"issue":"3","key":"3929_CR29","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1136\/annrheumdis-2013-204573","volume":"73","author":"JS Smolen","year":"2014","unstructured":"Smolen JS, Landewe R, Breedveld FC, Buch M, Burmester G, Dougados M, Emery P, Gaujoux-Viala C, Gossec L, Nam J, Ramiro S, Winthrop K, de Wit M, Aletaha D, Betteridge N, Bijlsma JW, Boers M, Buttgereit F, Combe B, Cutolo M, Damjanov N, Hazes JM, Kouloumas M, Kvien TK, Mariette X, Pavelka K, van Riel PL, Rubbert-Roth A, Scholte-Voshaar M, Scott DL, Sokka-Isler T, Wong JB, van der Heijde D (2014) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis 73(3):492\u2013509. \n                    https:\/\/doi.org\/10.1136\/annrheumdis-2013-204573","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"3929_CR30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/annrheumdis-2015-207524","volume":"75","author":"JS Smolen","year":"2016","unstructured":"Smolen JS, Breedveld FC, Burmester GR, Bykerk V, Dougados M, Emery P, Kvien TK, Navarro-Compan MV, Oliver S, Schoels M, Scholte-Voshaar M, Stamm T, Stoffer M, Takeuchi T, Aletaha D, Andreu JL, Aringer M, Bergman M, Betteridge N, Bijlsma H, Burkhardt H, Cardiel M, Combe B, Durez P, Fonseca JE, Gibofsky A, Gomez-Reino JJ, Graninger W, Hannonen P, Haraoui B, Kouloumas M, Landewe R, Martin-Mola E, Nash P, Ostergaard M, Ostor A, Richards P, Sokka-Isler T, Thorne C, Tzioufas AG, van Vollenhoven R, de Wit M, van der Heijde D (2016) Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Ann Rheum Dis 75(1):3\u201315. \n                    https:\/\/doi.org\/10.1136\/annrheumdis-2015-207524","journal-title":"Ann Rheum Dis"},{"issue":"31","key":"3929_CR31","doi-asserted-by":"publisher","first-page":"11419","DOI":"10.1073\/pnas.1410854111","volume":"111","author":"L Stangenberg","year":"2014","unstructured":"Stangenberg L, Burzyn D, Binstadt BA, Weissleder R, Mahmood U, Benoist C, Mathis D (2014) Denervation protects limbs from inflammatory arthritis via an impact on the microvasculature. Proc Natl Acad Sci U S A 111(31):11419\u201311424. \n                    https:\/\/doi.org\/10.1073\/pnas.1410854111","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"3929_CR32","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.crohns.2011.11.004","volume":"6","author":"F Tavano","year":"2012","unstructured":"Tavano F, di Mola FF, Latiano A, Palmieri O, Bossa F, Valvano MR, Latiano T, Annese V, Andriulli A, di Sebastiano P (2012) Neuroimmune interactions in patients with inflammatory bowel diseases: disease activity and clinical behavior based on Substance P serum levels. Journal of Crohn's & colitis 6(5):563\u2013570. \n                    https:\/\/doi.org\/10.1016\/j.crohns.2011.11.004","journal-title":"Journal of Crohn's & colitis"},{"issue":"6","key":"3929_CR33","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1136\/annrheumdis-2012-202846","volume":"72","author":"R Terenzi","year":"2013","unstructured":"Terenzi R, Romano E, Manetti M, Peruzzi F, Nacci F, Matucci-Cerinic M, Guiducci S (2013) Neuropeptides activate TRPV1 in rheumatoid arthritis fibroblast-like synoviocytes and foster IL-6 and IL-8 production. Ann Rheum Dis 72(6):1107\u20131109. \n                    https:\/\/doi.org\/10.1136\/annrheumdis-2012-202846","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"3929_CR34","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1124\/jpet.115.230060","volume":"356","author":"I Tsilioni","year":"2016","unstructured":"Tsilioni I, Russell IJ, Stewart JM, Gleason RM, Theoharides TC (2016) Neuropeptides CRH, SP, HK-1, and inflammatory cytokines IL-6 and TNF are increased in serum of patients with fibromyalgia syndrome, implicating mast cells. J Pharmacol Exp Ther 356(3):664\u2013672. \n                    https:\/\/doi.org\/10.1124\/jpet.115.230060","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"3929_CR35","first-page":"425","volume":"24","author":"A Vatrella","year":"2010","unstructured":"Vatrella A, Montagnani S, Calabrese C, Parrella R, Pelaia G, Biscione GL, Corcione N, Marsico SA, Guerra G (2010) Neuropeptide expression in the airways of COPD patients and smokers with normal lung function. J Biol Regul Homeost Agents 24(4):425\u2013432","journal-title":"J Biol Regul Homeost Agents"},{"issue":"1","key":"3929_CR36","doi-asserted-by":"publisher","first-page":"94","DOI":"10.2174\/1874312901409010094","volume":"9","author":"Q Wang","year":"2015","unstructured":"Wang Q, Zhou X (2015) Associations of MICA polymorphisms with inflammatory rheumatic diseases. The open rheumatology journal 9(1):94\u2013100. \n                    https:\/\/doi.org\/10.2174\/1874312901409010094","journal-title":"The open rheumatology journal"},{"issue":"2","key":"3929_CR37","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/apha.12428","volume":"213","author":"JV Weinstock","year":"2015","unstructured":"Weinstock JV (2015) Substance P and the regulation of inflammation in infections and inflammatory bowel disease. Acta physiologica (Oxford, England) 213(2):453\u2013461. \n                    https:\/\/doi.org\/10.1111\/apha.12428","journal-title":"Acta physiologica (Oxford, England)"}],"updated-by":[{"DOI":"10.1007\/s10067-020-05103-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T00:00:00Z","timestamp":1588896000000}}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-017-3929-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-017-3929-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-017-3929-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T19:05:03Z","timestamp":1588964703000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-017-3929-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,18]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["3929"],"URL":"https:\/\/doi.org\/10.1007\/s10067-017-3929-6","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s10067-020-05103-6","asserted-by":"object"}]},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,18]]},"assertion":[{"value":"22 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2020","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Following publication, it was brought to the authors\ufffd\ufffd\ufffd attention by Dr. Julia Toscano-Garibay that she did not participate as a reviewer of the final version of this manuscript prior to its submission and publication in Clinical Rheumatology.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}